177lu-psma-617
novartis
['177lu,psma,617', '#vision', 'crpc']
tolerability of [177lu]lu-psma-617 by treatment exposure in patients with #mcrpc: a #vision study subgroup analysis. presentation by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology